MAP4343

· Mapreg

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAP4343, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode [Phase 2]

See pricing